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After allergen application to skin, there is enhanced class II 
major histocompatibility complex antigen expression, as 
well as enhanced T -cell - stimulatory function by epidermal 
Langerhans cells (LC~. In this stu~y, we inves~igated tl~e 
early changes in the epidermal cytokme profile usmg a sensi-
tive reverse transcriptase PCR technique to determine 
whether cytokines may be related to LC activation. We 
A lthough it is well known that hapten-modified Lan-gerhans cells (LC) migrate from the e idermis to re-gionallymph nodes after application oFI1apten to skin [1-4], metabolic changes that occur in cells within the epidermis after hapten painting are less well charac-
terized. Prior studies demonstrated that after application of hap tens, 
but not primary irritants, a significan~ per.centage of. ~c: in the 
epidermis exhibit enhanced class II major 11lStocompatlblhty com-
plex (MHC) ex~r~ssion and that LC ob~ained 24 h aft.er hapten 
painting also exhibited enhanced syngeneic and allogeneic T -cell-
stimulatory function when compared to control LC [5,6]. These 
phenotypic and functional changes of LC are consistent with those 
seen when LC are cultured for short periods [7]. 
Several questions arise from these studies, namely, 1) what factors 
are responsible for enhanc~d class II expressi~n by LC hI viv~ after 
hapten painting?, 2) what mduces th~ migration ~f these activated 
LC to the regional lymph nodes?, 3) IS LC migratIOn necessary for 
the induction of allergic contact sensitization?, and 4) if the answer 
to 3 is yes, what happens if one abrogates the ill vivo activation of 
LC? 
To address the first question we have attempted to identify the 
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Abbreviations: 
DCNB: dichloronitrobenzene 
DNCB: dinitrochlorobenzene 
DNFB: dinitrofluorobenzene 
DNTB: dinitrothiocyanobenzene 
EC: epidermal cell 
GM-CSF: granulocyte/macrophage colony-stimulating factor 
IFN: interferon 
IL-1: interleukin 1 
IP-IO: interferon-induced protein 10 
KC: keratinocyte 
LC: Langerhans cell 
MHC: major histocompatibility complex 
MIP-2: macrophage inflammatory protein 2 
RT-PCR: reverse transcriptase polymerase chain reaction 
SLS: sodium lauryl sulfate 
TN CB: trinitrochlorobenzenc 
TNF: tumor necrosis factor 
found that, on the mRNA and protein level, changes in the 
epidermal cytokine pattern caused by allergens in the induc-
tion phase of contact sensitivity are distinct from those caused 
by irritants or tolerogens. The earliest of the changes is the 
LC-derived interleukin (IL) 1pmRNA signal strength that is 
increased within 15 min of allergen painting.] Invest Dermatol 
99:39S-41S, 1992 
factor or factors responsible for the hapten-induced activation of 
LC. We hypothesized that it is possible that haptens might directly 
affect LC class II MHC antigen expression through cytokine (or 
growth factor) induction and that cytokines may function through 
autocrine or paracrine mechanisms. 
To investigate the early changes in the epidermal cytokine profile 
we used a sensitive reverse transcriptase polymerase chain reaction 
(RT-PCR) technique in combination with liquid hybridization to 
quantitatively assess cytokine mRNA signals. Liquid hybridization 
is a technique where a specific internal 32p - end-labeled probe 
added in excess is hybridized to a defined amount of the PCR prod-
uct, resulting in signal strengths that are dependent on the amount 
of specific product present in the PCR mix. To ensure quantitative 
comparability, standard titrations for PCR cycles, primer concen-
trations, and amounts of RNA must be established to document 
linearity. Thus signal strength at various times after hapten painting 
can only be compared to the baseline signal of each individual 
mRNA. 
RNA was extracted from nonpainted skin and at various times 
after chemical [3% trinitrochlorobenzene (TNCB), 2% dinitro-
chloroben.zene (DNCB), 0.5% dinitrofluorobenzene (DNFB), 
20% sodIUm lauryl sulfate (SLS), 2% dichloronitrobenzene 
(I~CN~), 2°~o dinitr?t~iocyanobenzene (DNTB), and the acetone/ 
olive 011 vehicle] pamtlllg and 100-200 ng were amplified by RT-
~CR using primers specific for tumor necrosis factor (TNF)-a, 
lllterieuklll (IL)-la, IL-lP, macrophage inflammatory protein 2 
(MIP-2), ~ranulocyte/macrophage colony-stimulating factor 
(GM-CSF), lllterferon gamma (IFN-y) , and I-Aa. Baseline mRNA 
signals were detected when primers for TNF-a, IL-la, IL-lP, 
MIP-2, GM-CSF, IFN-y, and I-Aa were used, whereas no mRNA 
was detected when primers for interferon-induced protein 10 (IP-
10) were used [8]. 
The pattern of mRNA production was different when signal 
~tr~ngth after allergen painting was compared to that after vehicle, 
Irritant, or tolerogen painting (Fig 1). Whereas TNF-a, IFN-y (not 
shown), and GM-CSF (not shown) were found to be upregulated 
even after nonspecific stimuli (including tolerogens like DNTB or 
DCNB or irritants like SLS), only contact sensitizers like TNCB, 
DNFB, and DNCB upregulated IL-la, IL-lP, MIP-2, IP-I0, or 
I-Aa mRNA (Fig 1). I-Aa mRNA signal strength was likewise 
enhanced only after allergen painting [8]. 
Increased IFN-y and IP-I0 signals were detected within 1.5 h 
after application of 3% TNCB, and peaked 2 - 4 h after skin paint-
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Figure L Comparison of mRNA signal strength induced by contact aller-
gens and tolerogens. RT-PCR and liquid hybridization were performed as 
described in the text. Hybridization products were run on a 4% polyacryl-
amide gel electrophoresis, dried, and autoradiographed. X-axis time points 
show contact allergens (TNCB, DNFB, DNCB) and tolerogens (DCNB, 
DNTB) as well as baseline (No Tx). The Y-axis represents the integrated 
signal strength (in arbitrary units) 4 h after hapten application. Signal 
strength was assessed by densitometric scanning and integration by Image 
1.36 software. 
ing. MIP-2 increased more than twofold at 2 h and more than 
tenfold at 4 h after skin painting when it reached its peak. Signal 
strength for IL-l{l and TNF-a mRN A increased within 15 ~in and 
30 min, respectively, of hapten painting and both reached their peak 
strength (more than tenfold upregulation) at 2-4 h after skin paint-
ing. The strength of the IL-la signal increased more than tenfold at 
2 h when it reached its peak. mRNA signal strength for class II I-Aa 
did not increase until 6 h after painting and did not reach its peak 
until 12 h after painting. The increased mRNA signals began to 
decrease after 12 h for TNF-a, MIP-2, and IL-la. IL-l{l and class II 
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I-Aa mRNA signals persisted at peak levels at least 24 h after skin 
painting. IP-I0 and IFN-y signals were no longer detectable after 8 
and 6 h, respectively. Actin signals did not change in response to 
haptens. 
The source of the mRNA signals was determined by depleting 
EC populations of LC, Thy 1+ DEC, and infiltrating T cells. Our 
data demonstrated that Langerhans cells were the primary source of 
the IL-l{l and class II I-Aa mRNA, whereas keratinocytes were the 
primary source of the IL-1a, TNF-a, IP-10, and MIP-2 and infil-
trating T cells were the source of the IFN-y [8]. 
To determine the potential biologic significance of our molecular 
findings and whether functional proteins were released, we tested 
the supernatants from cultures containing either TNBS03-treated 
or untreated EC cultures for several biologically active or immuno-
reactive cytokines. Supernatants from haptenated, but not nonhap-
tenated, supernatants contained IL-la and TNF-a protein. Immu-
noreactive IFN-y was not detected. 
Taken together, our data indicate that haptens that are capable of 
inducing allergic contact sensitivity cause selective profound 
changes in the signal strength of the mRNA of several cytokines. 
The earliest of these changes is seen in the IL-1{l mRNA signal 
strength that is increased as early as 15 min after hapten painting. 
The cell-depletion studies indicate that the IL-1{l mRNA signal 
comes almost entirely from epidermal Langerhans cells and, al-
though our bioassays could not detect IL-l{l protein, we assume that 
our assay system was not sensitive enough to detect the miniscule 
amounts produced by LC. . 
There is probably no single cytokine, but several that act in con-
cert, that ultimately determine whether contact sensitivity ensues 
following the topical application of various chemicals [9,10]. Most 
of the cytokines studied are pro-inflammatory and some are induced 
nonspecifically. Both the inflammation and the LC activation that 
follow the application of haptens to skin may occur as a result of the 
EC cytokines that are induced. In a speculative scenario it may 
therefore be the epidermal LC that "decides" whether a chemical 
should be handled as an allergen or as a tolerogen. After hapten 
painting it may be that IL-1{l is released in the case of a recognized 
allergen or other (unknown) factors are released in the case of a 
tolerogen. The release of IL-1{l in turn could stimulate not only 
keratinocytes or T cells but also other LC through their IL-1 R in an 
autocrine fashion. This may lead to a group of "activated" LC, KC, 
and T cells that are triggered to produce other soluble factors like 
IL-1a, MIP-2, IFN-y, TNF-a, and others, and expression of class II 
molecules and cell migration. Finally there may even be counterreg-
ulatory mechanisms that function through the release of, e.g., IL-
10. Utilizing recombinant cytokines and more sensitive cytokine 
assays, the relative contribution of each cytokine in the evolution of 
allergic contact sensitivity can better be delineated. 
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